Company Profiles

driven by the PitchBook Platform

AbGenomics International

Description

Developer of antibody therapeutics designed for the treatment of cancer and immune-related inflammatory diseases. The company's antibody therapeutics focus on the discovery and development of novel therapeutics for unmet medical needs in the field of antibody-drug conjugates (ADC) therapy as well as creates a linker-payload that can be utilized for different targeted tumor indications, providing patients with long term drug-free remission of other immune-mediated diseases.

2000

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$16M

Latest Deal Amount

$48.6M

Total Amount Raised

Description

Developer of antibody therapeutics designed for the treatment of cancer and immune-related inflammatory diseases. The company's antibody therapeutics focus on the discovery and development of novel therapeutics for unmet medical needs in the field of antibody-drug conjugates (ADC) therapy as well as creates a linker-payload that can be utilized for different targeted tumor indications, providing patients with long term drug-free remission of other immune-mediated diseases.

Website:

www.abgenomics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Delivery
Drug Discovery

Primary Office

San Francisco, CA United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AbGenomics International's full profile, request a free trial.

AbGenomics International Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AbGenomics International Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Rong-Hwa Lin Ph.DChief Executive Officer, Founder & Chairman
Jim EarlyChief Financial Officer
Leewen Lin Ph.DChief Operating Officer
Lingzhi SunController
Cheng-Chi Chao Ph.DSenior Director, Technology and Business Development
Rong-Hwa Lin Ph.D Chief Executive Officer, Founder & Chairman
Jim Early Chief Financial Officer
Leewen Lin Ph.D Chief Operating Officer
Lingzhi Sun Controller
Cheng-Chi Chao Ph.D Senior Director, Technology and Business Development

AbGenomics International Board Members (9)

NameRepresentingRoleSinceContact
Info
Chia YangSelfBoard Member000 0000
Chung Yung-HuaSelfBoard Member000 0000
Kim GrahamAbGenomics InternationalBoard Member000 0000
Nai-Yu PaiAbGenomics InternationalBoard Member000 0000
Stephen Polmar MDAbGenomics InternationalBoard Member000 0000
Chia Yang Board Member Self
Chung Yung-Hua Board Member Self
Kim Graham Board Member AbGenomics International
Nai-Yu Pai Board Member AbGenomics International
Stephen Polmar MD Board Member AbGenomics International
Request full access to PitchBook